TERMINATION OF AGREEMENT AND RELEASESTermination of Agreement and Releases • November 13th, 2006 • Avantogen Oncology, Inc. • Non-operating establishments • California
Contract Type FiledNovember 13th, 2006 Company Industry JurisdictionAGREEMENT dated as of November 6, 2006, between SUPRATEK PHARMA, INC. (“SPI”), on the one hand, and AVANTOGEN ONCOLOGY, INC., formerly known as Innovate Oncology, Inc. (“AOI”), and GARDANT PHARMACEUTICALS INC., formerly known as Bioaccelerate Holdings Inc. (“GDT”), severally, on the other hand.
TERMINATION OF AGREEMENT AND RELEASESTermination of Agreement and Releases • May 31st, 2007 • Avantogen Oncology, Inc. • Non-operating establishments • California
Contract Type FiledMay 31st, 2007 Company Industry JurisdictionThis AGREEMENT (this “Agreement”), dated as of May 18, 2007, is entered into between PROSTAGENICS LLC, a New York limited liability company (“Prostagenics”), on the one hand, and AVANTOGEN ONCOLOGY, INC., a Nevada corporation formerly known as Innovate Oncology, Inc. (“AOI”), on the other hand.